Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0376
-0.0023 (-5.76%)
At close: Oct 19, 2026

RMTG Revenue

Regenerative Medical Technology Group had revenue of $4.02M in the quarter ending June 30, 2026, with 309.10% growth. This brings the company's total for the last twelve months to $9.41M, up 94.32% year-over-year. In the year 2025, Regenerative Medical Technology Group had annual revenue of $5.10M with 24.17% growth. That makes Regenerative Medical Technology Group the 37,611th largest company in the world by revenue and 4,945th in the United States.

Revenue (ttm)
9.41M
Revenue Growth
+94.32%
P/S Ratio
0.06
Revenue / Employee
9.41M
Employees
1
Market Cap
598.36K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.10M992.82K24.17%
Dec 31, 20244.11M1.70M70.44%
Dec 31, 20232.41M879.73K57.49%
Dec 31, 20221.53M1.09M249.46%
Dec 31, 2021437.89K382.81K694.97%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Evofem Biosciences18.05M
SQZ Biotechnologies Company12.12M
Helix BioMedix2.07M
Orgenesis1.04M
Halberd6.94K
Revenue Rankings